Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03253536 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma

Study acronym: LIVERCARE
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 18, 2017 (before its estimated July 10, 2022 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Prospective single arm, single center observational study to evaluate Quality of Life (Qol) after stereotactic body radiotherapy for patients with hepatocellular cancer. Patients will receive work-up, treatment and follow-up exclusively as routinely done except additional quality of life measurements. Qol will be measured by standardized and validated EORTC questionaires at different time points during routine follow-up.
Trial Details
NCT Number NCT03253536
Lead Sponsor Ludwig-Maximilians - University of Munich
Conditions
(from sponsor)		 Hepatocellular Cancer, Quality of Life, Stereotactic Body Radiation Therapy, Observational
Related terms Liver Neoplasms
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov